Breast cancer

A new study claims a novel blood test can identify breast cancer years before clinical signs of the disease appear. The blood test is only in its preliminary stages of development, however, some scientists are skeptical of the researchers’ claims.

In preclinical tests, scientists at Wistar Institute have developed a molecule that disrupts a protein complex vital to cancer cell survival.

A study suggests the drugs used to initially treat breast cancer may be triggering some cancer cells to enter a dormant state.

A new blood test has been developed that promises to be able to effectively track the progression of breast cancer at its earliest stages. It is suggested the blood test could track the efficacy of drug therapies better than current imaging techniques and prevent unnecessary surgical procedures.

Cancer cells often deploy specific “don't eat me” signals to hide from immune cells. A breakthrough new study has homed in on a previously undiscovered signalling protein that, if effectively inhibited, may lead to new treatments for breast, ovarian, and other difficult-to-treat cancers.

CAR-T cell therapy involves reprogramming T-cells to hunt down cancer, which has been effective against blood cancers but not so much against solid tumors. Now, scientists at MIT have found a way to supercharge the technique with a vaccine booster.

New research from the University of Virginia suggests an unhealthy gut microbiome can actively promote the spread of breast cancer. Through a series of animal experiments the new study demonstrated how disruptions to gut bacterial populations can drive metastatic spread of tumor cells.

A deep learning model, trained on thousands of mammograms, can now predict whether a person is at a high risk of developing breast cancer. Better than any current model, the new system can identify subtle changes in breast tissue and determine how likely cancer could develop within five years.

Cancer might not be so difficult to kill if it didn’t have the terrifying ability to spread throughout the body. Now, researchers have discovered a particular protein signalling pathway that controls whether a tumor can spread or not, making it a good target for future drugs.

Part of cancer's cunning is its ability to spread around the body, so that doctors can rarely be sure they’ve killed it all. Now researchers have identified a drug that could help keep cancer contained in a dormant state – and best of all, that drug is already on the market for other purposes.

Researchers in Vienna are making some promising progress in the field of breast cancer detection, developing a new method that revolves around a waistcoat packed with flexible radio frequency coils.